Pērciet Finasterīdu

Inhibits type II 5-alpha reductase, which converts testosterone into the more active 5-alpha dihydrotestosterone, reduces its concentration in the blood and prostate tissue within 24 hours after oral administration. Inhibits the stimulating effect of testosterone on tumor development. Suppression of the formation of dihydrotestosterone is accompanied by a decrease in the volume of the prostate gland, an increase in the maximum flow rate of urine and a decrease in symptoms of urinary tract obstruction. With constant administration, a statistically significant effect is recorded after 3 months (decrease in the volume of the gland), 4 months (increase in the maximum flow rate of urine) and 7 months (decrease in general symptoms and symptoms of urinary tract obstruction). When you stop taking the drug, changes in the prostate gland are restored within 6-8 months.

Prostate cancer

Results from a 2005 study at the National Cancer Institute (USA) showed that when taking 5 mg per day, as is usually prescribed for BPH, study participants taking finasteride had 25% fewer cases of prostate cancer at the end of the study. compared with patients receiving placebo.

contraindications:

• Hypersensitivity,
• pregnancy,
• women of childbearing age,
• children.

With care:

• Hepatic failure,
• obstructive uropathy.

Special instructions

In patients with a large volume of residual urine and / or a sharply reduced urine flow, careful monitoring of the possible development of obstructive uropathy is necessary. Before starting therapy, it is necessary to exclude diseases that simulate benign prostatic hyperplasia - prostate cancer, urethral stricture, bladder hypotension, disturbances of its innervation and infectious prostatitis.

Women of childbearing age and pregnant women should avoid contact with the drug, it has teratogenic properties (the ability to suppress the conversion of testosterone to dihydrotestosterone can cause impaired development of the genital organs in a male fetus), penetrates into the seminal fluid.

Causes a decrease in prostate-specific antigen after 6 and 12 months of admission by 41 and 48%, respectively. Patient examinations are necessary to exclude the development of prostate cancer during therapy with finasteride.

• Allergic reactions (rash, pruritus, urticaria, swelling of the lips and face),
• decreased potency and / or libido,
• impaired ejaculation,
• decreased ejaculate volume,
• increase and soreness of the mammary glands,
• increased concentration of luteinizing hormone and follicle-stimulating hormone in the blood,
• decreased concentration of prostate specific antigen (PSA).

For the treatment of prostate adenoma by mouth, regardless of food intake, 5 mg once a day.

For the treatment of alopecia by mouth, regardless of food intake, 1 mg 1 time per day. (divide the 5 mg tablet into parts and take 1/4 or 1/5 daily.

Jūs varat iegādāties Finasteride no mūsu vietnes pilnīgi likumīgi.

Piegāde tiek veikta uz visām pasaules valstīm, kurās nav oficiāla pasta saņemšanas un nosūtīšanas aizlieguma (galvenokārt salu valstis).

Mēs garantējam, ka jūs bez problēmām saņemsiet savu paku ar Finasteride muitā (mums ir savi piegādes kanāli uz valstīm ar stingru muitu).

Mēs garantējam naudas atmaksu, ja jūsu paka jums nav piegādāta kāda iemesla dēļ saskaņā ar PayPal aizsardzības politiku.

Karantīnas dēļ piegādes laiks var nedaudz palielināties, taču piegāde joprojām saglabājas saprātīgās robežās un nepārsniedz piegādes laiku Ziemassvētku izpārdošanas laikā.

Recepte nav nepieciešama!

Jūs varat legāli iegādāties Finasteride mūsu vietnē bez receptes.